Published in Tex Heart Inst J on January 01, 2009
A pathway to leadership for adult immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on June 14, 2011. Public Health Rep (2012) 1.18
Perceptions of and willingness to engage in public health precautions to prevent 2009 H1N1 influenza transmission. BMC Public Health (2011) 0.94
Determinants of refusal of A/H1N1 pandemic vaccination in a high risk population: a qualitative approach. PLoS One (2012) 0.93
Acute myocardial infarction and influenza: a meta-analysis of case-control studies. Heart (2015) 0.82
Influenza vaccine as a coronary intervention for prevention of myocardial infarction. Heart (2016) 0.81
The challenge of vaccinating adults: attitudes and beliefs of the Canadian public and healthcare providers. BMJ Open (2015) 0.81
Intanza (®) 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age. Hum Vaccin Immunother (2013) 0.78
The public acceptance of smallpox vaccination to fight bioterrorism in Japan: results of a large-scale opinion survey in Japan. Environ Health Prev Med (2010) 0.76
Safety and tolerability of intradermal influenza vaccination in patients with cardiovascular disease. J Geriatr Cardiol (2014) 0.75
A Blueprint for Improving the Promotion and Delivery of Adult Vaccination in the United States. Rand Health Q (2012) 0.75
Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2008) 15.35
Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA (2000) 8.31
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation (2006) 8.01
The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med (2001) 7.49
The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med (1994) 5.38
Risk factors of influenza transmission in households. Br J Gen Pract (2004) 5.25
The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med (1995) 5.21
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2004) 5.00
Emerging infections: pandemic influenza. Epidemiol Rev (1996) 4.85
Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA (1999) 3.71
Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med (2003) 3.49
Physical exertion as a trigger of acute myocardial infarction. Triggers and Mechanisms of Myocardial Infarction Study Group. N Engl J Med (1993) 3.15
Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. Am J Public Health (1986) 2.90
Population-wide benefits of routine vaccination of children against influenza. Vaccine (2005) 2.68
Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis (1970) 2.53
Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects. Eur Heart J (2007) 2.07
Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med (1998) 2.03
Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine (2005) 1.97
Association between influenza vaccination and reduced risk of brain infarction. Stroke (2002) 1.81
Influenza and cardiovascular disease: is there a causal relationship? Tex Heart Inst J (2004) 1.39
Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation (2000) 1.29
Update: influenza vaccine supply and recommendations for prioritization during the 2005-06 influenza season. MMWR Morb Mortal Wkly Rep (2005) 1.29
Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation (2002) 1.28
Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Circulation (2006) 1.28
Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J (2008) 1.19
Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation (2003) 1.16
Influenza and pneumococcal immunization in diabetes. Diabetes Care (2004) 1.11
Influenza vaccination is associated with a reduced risk of stroke. Stroke (2005) 1.10
Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol (2000) 1.06
Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol (2002) 1.06
Influenza vaccination levels among persons aged > or =65 years and among persons aged 18-64 years with high-risk conditions--United States, 2003. MMWR Morb Mortal Wkly Rep (2005) 1.02
A study of illness in a group of Cleveland families. V. Introductions and secondary attack rates as indices of exposure to common respiratory diseases in the community. Am J Hyg (1953) 0.97
Influenza vaccination of persons with cardiovascular disease in the United States. Tex Heart Inst J (2004) 0.95
Of birds and men: cardiologists' role in influenza pandemics. Lancet (2004) 0.88
Examining the coverage of influenza vaccination among people with cardiovascular disease in the United States. Am Heart J (2005) 0.82
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation (2003) 8.61
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation (2003) 3.94
Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol (2004) 2.74
The role of periadventitial fat in atherosclerosis. Arch Pathol Lab Med (2007) 2.59
Influenza and cardiovascular disease: is there a causal relationship? Tex Heart Inst J (2004) 1.39
Cellular association and assembly of a multistage delivery system. Small (2010) 1.32
Biomedical applications of functionalized fullerene-based nanomaterials. Int J Nanomedicine (2009) 1.19
Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation (2003) 1.16
Ewing's sarcoma of the kidney. Int J Clin Oncol (2010) 1.04
Temporal trends in anti-diabetes drug use in TRICARE following safety warnings in 2007 about rosiglitazone. Pharmacoepidemiol Drug Saf (2009) 1.03
Antioxidant single-walled carbon nanotubes. J Am Chem Soc (2009) 0.99
Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gamma. Circulation (2003) 0.99
Self assembly of amphiphilic C60 fullerene derivatives into nanoscale supramolecular structures. J Nanobiotechnology (2007) 0.98
Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromes. Tex Heart Inst J (2007) 0.96
Telephone survey to assess influenza-like illness, United States, 2006. Emerg Infect Dis (2008) 0.95
Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice. Atherosclerosis (2009) 0.94
Buckysomes: fullerene-based nanocarriers for hydrophobic molecule delivery. ACS Nano (2008) 0.94
An iodinated liposomal computed tomographic contrast agent prepared from a diiodophosphatidylcholine lipid. Nanomedicine (2008) 0.91
Intracoronary thermography for detection of high-risk vulnerable plaques. J Am Coll Cardiol (2006) 0.91
Semantic web representation of LOINC: an ontological perspective. AMIA Annu Symp Proc (2006) 0.89
Antibody-labeled liposomes for CT imaging of atherosclerotic plaques: in vitro investigation of an anti-ICAM antibody-labeled liposome containing iohexol for molecular imaging of atherosclerotic plaques via computed tomography. Tex Heart Inst J (2009) 0.88
Utilizing a trauma systems approach to benchmark and improve combat casualty care. J Trauma (2010) 0.88
Of birds and men: cardiologists' role in influenza pandemics. Lancet (2004) 0.88
Thermography basket catheter: in vivo measurement of the temperature of atherosclerotic plaques for detection of vulnerable plaques. Catheter Cardiovasc Interv (2003) 0.86
Contact- and agonist-regulated microvesiculation of human platelets. Thromb Haemost (2013) 0.85
Information integration from heterogeneous data sources: a Semantic Web approach. AMIA Annu Symp Proc (2006) 0.84
Racial and ethnic health disparities in TRICARE. J Natl Med Assoc (2009) 0.83
Dendro[C(60)]fullerene DF-1 provides radioprotection to radiosensitive mammalian cells. Radiat Environ Biophys (2010) 0.79
Cholesterol crystallization and macrophage apoptosis: implication for atherosclerotic plaque instability and rupture. Biochem Pharmacol (2003) 0.79
Silent myocardial ischemia: Current perspectives and future directions. Exp Clin Cardiol (2007) 0.77
Three-dimensional isotropic wavelets for post-acquisitional extraction of latent images of atherosclerotic plaque components from micro-computed tomography of human coronary arteries. Acad Radiol (2007) 0.77
Decreasing body temperature predicts early rehospitalization in congestive heart failure. J Card Fail (2008) 0.77
Admission body temperature and mortality in elderly patients hospitalized for heart failure. J Am Coll Cardiol (2006) 0.77
Association of low body temperature and poor outcomes in patients admitted with worsening heart failure: a substudy of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) trial. Eur J Heart Fail (2013) 0.77
Usefulness of multidetector computed tomography for noninvasive evaluation of coronary arteries in asymptomatic patients. Am J Cardiol (2005) 0.76
Circadian body temperature variability is an indicator of poor prognosis in cardiomyopathic hamsters. J Card Fail (2010) 0.76
Quantification of roughness of calcific deposits in computed tomography scans of human coronary arteries. Invest Radiol (2007) 0.76
Coronary thermography for detection of vulnerable plaques. J Nucl Cardiol (2007) 0.76
Semantic approach for text understanding of chief complaints data. AMIA Annu Symp Proc (2006) 0.76
Nanotechnology and atherosclerosis imaging: emerging diagnostic and therapeutic applications. Recent Pat Cardiovasc Drug Discov (2008) 0.76
Devices in heart failure: potential methods for device-based monitoring of congestive heart failure. Tex Heart Inst J (2008) 0.75
Services oriented architectures and rapid deployment of ad-hoc health surveillance systems: lessons from Katrina relief efforts. AMIA Annu Symp Proc (2006) 0.75
Thermography to detect inflamed macrophage-rich plaques. Circulation (2003) 0.75
How to achieve a high-performance health care system in the United States. Ann Intern Med (2008) 0.75
The open-artery hypothesis revisited. Tex Heart Inst J (2006) 0.75
Humanitarian assistance and disaster relief: changing the face of defense. Am J Disaster Med (2009) 0.75
Department of Defense Global Emergings Infections Surveillance and Response System. Mil Med (2008) 0.75
Thoughts on the role of the healing professions and the events of September 11, 2001. Circulation (2002) 0.75
A pilgrimage. Mil Med (2009) 0.75
Comparison of 60-day mortality in hospitalized heart failure patients with versus without hypothermia. Am J Cardiol (2006) 0.75
Guantanamo: ethics, interrogation, and forced feeding. Mil Med (2009) 0.75
First-trimester prenatal screening for the common 35delG GJB2 mutation causing prelingual deafness. Prenat Diagn (2004) 0.75
Vascular stem cells: a new concept in the pathogenesis of atherosclerosis and interventions for coronary heart disease. Future Cardiol (2006) 0.75